SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-23-006469
Filing Date
2023-04-24
Accepted
2023-04-24 07:17:18
Documents
15
Period of Report
2023-04-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K amph-20230421x8k.htm   iXBRL 8-K 66884
2 EX-99.1 amph-20230421xex99d1.htm EX-99.1 61922
3 GRAPHIC amph-20230421xex99d1001.jpg GRAPHIC 6890
4 GRAPHIC amph-20230421xex99d1002.jpg GRAPHIC 4387
  Complete submission text file 0001558370-23-006469.txt   278702

Data Files

Seq Description Document Type Size
5 EX-101.SCH amph-20230421.xsd EX-101.SCH 3365
6 EX-101.LAB amph-20230421_lab.xml EX-101.LAB 15363
7 EX-101.PRE amph-20230421_pre.xml EX-101.PRE 10387
9 EXTRACTED XBRL INSTANCE DOCUMENT amph-20230421x8k_htm.xml XML 4681
Mailing Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730
Business Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730 909-980-9484
Amphastar Pharmaceuticals, Inc. (Filer) CIK: 0001297184 (see all company filings)

IRS No.: 330702205 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36509 | Film No.: 23837932
SIC: 2834 Pharmaceutical Preparations